Treatment of syphilis 2001: Nonpregnant adults

Clinical Infectious Diseases

Volumn 35, Issue SUPPL. 2, 2002, Pages

  Augenbraun, Michael H ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G; PROCAINE PENICILLIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MEDICAL LITERATURE; META ANALYSIS; NEUROSYPHILIS; PEER REVIEW; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFTRIAXONE; DATABASES, FACTUAL; ETHYLENEDIAMINES; HIV INFECTIONS; HUMANS; INCIDENCE; NEUROSYPHILIS; OUTCOME ASSESSMENT (HEALTH CARE); PENICILLINS; SYPHILIS; UNITED STATES;

EID: 0037108395     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342106     Document Type: Article

References (25)

1. Gould S. Syphilis and the shepherd of Atlantis. Natural History 2000;10:38-82.
2. Centers for Disease Control and Prevention. The national plan to eliminate syphilis from the United States, 1999. Public Health Service. Washington, DC: US Government Printing Office, 1999.
3. Johns D, Tierney M, Felsenstein D. Alterations in the natural history of neurosyphilis by concurrent infection with the human immuno-deficiency virus. N Engl J Med 1987;316:1569-72.
4. Berry C, Hooton T, Collier A, Lukehart S. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987;316:1587-9.
5. Centers for Disease Control and Prevention. STD treatment guidelines, 1982. MMWR Morb Mortal Wkly Rep 1982;31(Suppl 2):S33-60.
6. Centers for Disease Control and Prevention. STD treatment guidelines, 1985. MMWR Morb Mortal Wkly Rep 1985;34(Suppl 4):S75-108.
7. Centers for Disease Control and Prevention. 1989 sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1989;38(Suppl 8):1-43.
8. 1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1993;42:1-102.
9. 1998 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;47:1-116.
10. Augenbraun M, Rolfs R. Treatment of syphilis, 1998: nonpregnant adults. Clin Infect Dis 1999;28(Suppl 1):S21-8.
11. Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. Ann Pharmacother 1998;32:785-93.
12. Stamm LV, Parrish EA. In vitro activity of azithromyicn and CP-63,956 against Treponema pallidu. J Antimicrob Chemother 1990;25(Suppl A):11-4.
13. Lukehart SA, Fohn MJ, Baker-Zander SA. Efficacy of azithromycin for the therapy of active syphilis in the rabbit model. J Antimicrob Chemother 1990;25(Suppl A):91-9.
14. Verdon MS, Handsfield HH, Johnson RB. Pilot study of azithromycin for the treatment of primary and secondary syphilis. Clin Infect Dis 1994;19:486-8.
15. Hook E III, Stephans J, Ennis DM. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med 1999;131:434-7.
16. Mashkilleyson AL, Gomberg MA, Mashkilleyson N, Kutin SA. Treatment of syphilis and azithromycin. Int J STD AIDS 1996;7(Suppl 1):13-5.
17. Gruber F, Kastelan M, Cabrijan L, Simonic E, Brajac I. Treatment of early syphilis with azithromycin. J Chemother 2000;12:240-3.
18. Hook EW III, Roddy RE, Handsfield HH. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis 1988;158:881-4.
19. Moorthy TT, Lee CT, Lim KB, Tan T. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sex Transm Dis 1987; 14:116-9.
20. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immundodeficiency virus-infected individuals. Clin Infect Dis 2000;30:540-4.
21. Augenbraun M, Workowski K. Ceftriaxone therapy for syphilis: report from the Emerging Infections Network. Clin Infect Dis 1999;29:1337-8.
22. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997;337:307-14.
23. Marra CM, Longstreith WT Jr, Maxwell CL, Lukehart SA. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis: influence of concomitant human immunodeficiency virus infection. Sex Transm Dis 1996;23:184-9.
24. Bordon J, Martinez-Vazquez C, Alvarez M, et al. Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1995;14:864-9.
25. Janier M, Chastang C, Spindler E, et al. A prospective study of the influence of HIV status on the seroreversion of serologic tests for syphilis. Dermatology 1999;198:362-9.